Ready To Welcome To...
Health Care: Drugs
Amgen Inc (AMGN: NASDAQ)
$105.70 0.08 | 0.08%
05/24/13 - 01:35 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 3.26B | 6.95B | 3.29B | 2.88B |
| Receivables | 2.52B | 2.90B | 2.34B | 2.11B |
| Inventories | 2.74B | 2.48B | 2.02B | 2.22B |
| Other Current Assets | 1.89B | 1.57B | 1.35B | 1.16B |
| Total Current Assets | 31.21B | 27.59B | 23.13B | 18.93B |
| Property, Plant & Equipment, Gross | 11.95B | 11.23B | 10.69B | 10.38B |
| Accumulated Depreciation & Depletion | 6.62B | 5.81B | 5.17B | 4.64B |
| Property, Plant & Equipment, Net | 5.33B | 5.42B | 5.52B | 5.74B |
| Intangibles | 3.97B | 2.58B | 2.23B | 2.57B |
| Other Non-Current Assets | 1.13B | 1.52B | 1.27B | 1.06B |
| Total Non-Current Assets | 23.09B | 21.28B | 20.36B | 20.70B |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 54.30B | 48.87B | 43.49B | 39.63B |
| Accounts Payable | 905.00M | 642.00M | 716.00M | 574.00M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 8.19B | 5.75B | 6.57B | 3.87B |
| Long Term Debt | 24.03B | 21.34B | 10.87B | 10.60B |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 3.01B | 2.74B | 2.10B | 2.49B |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 27.05B | 24.09B | 12.97B | 13.09B |
| Total Liabilities | 35.24B | 29.84B | 19.54B | 16.96B |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 19.06B | 19.03B | 23.94B | 22.67B |
| Common Par | 29.34B | 27.78B | 27.30B | 26.94B |
| Additional Paid In Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -10.42B | -8.92B | -3.51B | -4.32B |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 146.00M | 171.00M | 153.00M | 45.00M |
| Total Capitalization | 43.09B | 40.37B | 34.82B | 33.27B |
| Total Equity | 19.06B | 19.03B | 23.94B | 22.67B |
| Total Liabilities & Stock Equity | 54.30B | 48.87B | 43.49B | 39.63B |
| Total Common Shares Outstanding | 756.30M | 795.60M | 932.00M | 995.00M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 775.00M | 905.00M | 960.00M | 1.02B |
| Diluted Weighted Shares Outstanding | 787.00M | 912.00M | 965.00M | 1.02B |
| Number of Employees | 18000 | 17500 | 17100 | 17000 |
| Number of Part-Time Employees | 0 | 300 | 300 | 200 |
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserDividend Stocks
- ContributorTechnical Setups for the We...
- ContributorTechnical Setups for the We...
- UserStevo
- ContributorPotential Dividend Hikes fo...
- UserMike Fatah's Mega Stock Por...
- UserGFNN Stockdiagnostics 23
- UserLong Term Stock Picks
Latest AMGN Headlines from TheStreet
- 5 Stocks Raising The Drugs Industry Higher 05.23.13 | 01:05 pm
- Amgen Inc (AMGN): Today's Featured Health Care Winner 05.21.13 | 05:05 pm
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Amgen Inc (AMGN): Today's Featured Drugs Winner 05.14.13 | 05:05 pm
- 5 Stocks Going Ex-Dividend Tomorrow: HR, PMT, CNP, GG, AMGN 05.13.13 | 10:05 am
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) 05.13.13 | 09:05 am
- Amgen Inc (AMGN): Today's Featured Health Care Laggard 05.06.13 | 05:05 pm
- 5 Stocks Dragging In The Health Care Sector 05.06.13 | 01:05 pm
- All the Reasons in the World to Pull Back 05.04.13 | 06:05 am
- Analysts' Actions: AMGN BIIB DWA FCX ULTI 05.01.13 | 08:05 am
Press Releases for AMGN
- Amgen To Present At The Deutsche Bank 38th Annual Healthcare Conference - PR Newswire 05.23.13 | 05:05 pm
- Amgen Announces Voting Results Of Annual Meeting Of Stockholders - PR Newswire 05.22.13 | 05:05 pm
- Amgen To Present At The UBS Global Life Sciences Conference - PR Newswire 05.16.13 | 04:05 pm
- Amgen Highlights Data To Be Presented At American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.15.13 | 06:05 pm
- Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - PR Newswire 05.09.13 | 04:05 pm
- Four Californians Selected As Breakaway From Cancer® Champions To Be Honored During Amgen Tour Of California - PR Newswire 05.01.13 | 04:05 pm
- Amgen Announces Webcast Of 2013 First Quarter Financial Results - PR Newswire 04.18.13 | 04:04 pm
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma - PR Newswire 03.19.13 | 06:03 pm
- Amgen Announces 2013 Second Quarter Dividend - PR Newswire 03.06.13 | 04:03 pm
Partner Headlines for AMGN
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Biotech Breakout Boosting ETFs - Benzinga 03.28.13 | 03:03 pm
- Wall St rises as Fed reaffirms policies - Financial Times 03.20.13 | 08:03 pm
- Celgene Leads Handful Of Big Cap Stocks To New Highs - Investor's Business Daily 03.11.13 | 06:03 pm
- When To Add A New Full Position In A Good Stock - Investor's Business Daily 03.11.13 | 06:03 pm
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013 - NASDAQ 02.27.13 | 02:02 pm
